Page last updated: 2024-10-26

diclofenac and Disbacteriosis

diclofenac has been researched along with Disbacteriosis in 2 studies

Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Ahlawat, S1
Shankar, A1
Mohan, H1
Sharma, KK1
Hodkovicova, N1
Hollerova, A1
Blahova, J1
Mikula, P1
Crhanova, M1
Karasova, D1
Franc, A1
Pavlokova, S1
Mares, J1
Postulkova, E1
Tichy, F1
Marsalek, P1
Lanikova, J1
Faldyna, M1
Svobodova, Z1

Other Studies

2 other studies available for diclofenac and Disbacteriosis

ArticleYear
Yersinia enterocolitica and Lactobacillus fermentum induces differential cellular and behavioral responses during diclofenac biotransformation in rat gut.
    Toxicology and applied pharmacology, 2021, 11-15, Volume: 431

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Biotransformation; Diclofenac; D

2021
Non-steroidal anti-inflammatory drugs caused an outbreak of inflammation and oxidative stress with changes in the gut microbiota in rainbow trout (Oncorhynchus mykiss).
    The Science of the total environment, 2022, Nov-25, Volume: 849

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Diclofenac; Disease Outbreaks; Dysbios

2022